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WEIGHT OR BIOMARKER FOR ASSESSING THE IODINE STATUS 
IN HEALTHY PREGNANT WOMEN, ONLY?
MAJA AVRAMOVSKA1, BORISLAV KARANFILSKI2, GORAN DIMITROV3, GLIGOR TOFOSKI3, 
ELENA DZIKOVA3, ANA DANEVA MARKOVA3, MARIJA HADZI-LEGA4, KOSTA SOTIROSKI5, 
OLIVIJA VASKOVA2, ALEKSANDAR SIKOLE6
1Clinical Hospital “Dr Trifun Panovski” – Bitola, Department of Obstetrics and Gynecology, Bitola, 
North Macedonia; 2Institute of Pathophysiology and Nuclear Medicine, Medical Faculty -Skopje, 
Ss. Cyril and Methodius University, Skopje, North Macedonia; 3University Clinic of Obstetrics and 
Gynecology, Medical Faculty -Skopje, Ss. Cyril and Methodius University, Skopje, North Macedonia; 
4Danat Al Emarat Hospital for Women and Children, Abu Dhabi, United Arab Emirates; 5Faculty 
of Economics – Prilep, Department of Statistics, St. Clement of Ohrid University – Bitola, North 
Macedonia; 6University Clinic of Nephrology, Medical Faculty -Skopje, Ss. Cyril and Methodius 
University, Skopje, North Macedonia
Introduction: This study determined urine iodine concentration (UIC) during gestation, assessed the maternal iodine nutrition 
status and correlated it with gestational age at birth (GAB) and birth weight (BW).The measurement of UIC provides the 
best single measurement of the iodine nutritional status in population. Objective: Determination of UIC in pregnant women 
in North Macedonia. Methods: This prospective study assessed the iodine nutrition status during the course of pregnancy 
with reference of median UIC among 364 healthy pregnant women in different gestational age (in trimester and 5-week 
intervals). Results: The overall and the 1st to the 3rd trimester median UIC were: 183.7, 207, 189.75 and 169.28 [μg/L], 
respectively. The median UIC (μg/L) results according to 5-week interval in advancing gestation were: 232.34, 200.13, 
152.81, 194.39, 181.28, 160.28, 169.41 and 175.24, respectively. We detected 5.22% (19/364) and 74.72% (272/364) with 
the median UIC < 50 μg/L and UIC ≥ 100 μg/L, respectively. In multiple regression, the median UIC (β = 0.0000767, P = 
0.929) had no statistically signifi cant prediction to the GAB. Disease prevalence results for mean UIC in detecting BW had 
no statistical signifi cance: area under curve (AUC) = 0.521, z-statistic (0.340), sensitivity (45.83%), specifi city (66.27%), 
predictive (6.59%) and P value (0.734). Conclusion: Iodine status of pregnant women in our study is generally suffi cient 
by World Health Organization recommendations. The median UIC in each trimester and 5-week interval has statistically 
insignifi cant decrease in accordance to the advancing gestation. The median UIC has no signifi cance in predicting GAB 
and BW.
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INTRODUCTION
Impaired maternal thyroid metabolism and thyroid 
hormones status are associated with poor outcomes 
for the mother and the developing newborn, preterm 
delivery, low birth weight, irreversible damage to the 
nervous system and intelligence of the fetus (1). Iodine 
is required for the production of thyroid hormones, 
which play a crucial role in fetal organogenesis, and 
in particular in brain development (2). Pregnancy is 
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associated with substantial changes in thyroid physiol-
ogy and represents a major stress on maternal homeo-
stasis. Th e need for iodine in pregnancy is increased 
(3) due to an increase in maternal thyroxine produc-
tion to maintain maternal euthyroidism and for trans-
fer of thyroid hormones to the fetus in early pregnan-
cy, before the fetal thyroid begins functioning (4). 
Th e majority of iodine absorbed by the body is excret-
ed in urine. Urine iodine excretion is largely a passive 
process (5) dependent on glomerular fi ltration rate 
(GFR). 
Th e maternal GFR is increased during pregnancy 
resulting in increased renal loss of ingested iodine, 
which results with an additional increase in urinary 
iodine concentration (UIC). In pregnancy, oncotic 
pressure is substantially decreased because of expan-
sion of the plasma volume, thus contributing to a rise 
in GFR (6, 7).UIC in nonpregnant women on a stable 
diet represents a dynamic equilibrium between dietary 
intakes, thyroidal iodine extraction, the total body 
thyroid hormone pool, and GFR (5). Pregnancy is a 
vasodilated state mediated by elevated levels of pro-
gesterone.GFR increases continuously within the fi rst 
month of pregnancy, and reaches its maximum of 40-
50% above the level before conception. In the second 
trimester GFR reached a plateau, and slowly decreased 
in the third trimester toward the pregnancy concentra-
tion (7). Pregnancy is a vasodilated state mediated by 
alterations in sensitivity to angiotensin II and elevated 
levels of progesterone. Progesterone has a diuretic ef-
fect which is related to aldosterone antagonism which 
results in increases of GFR (5 - 7). Increased nitric ox-
ide production that occur during normal pregnancy 
results in cardiac output rising and abets the expan-
sions of plasma volume by stimulating renal sodium 
and water retention. Both increased renal blood fl ow 
and decreased oncotic pressure due to plasma volume 
expansion contribute to higher GFR (3).
A higher GFR during pregnancy results in decreased 
circulating creatinine and a possible trend toward 
lower urinary creatinine concentrations (7, 8). Hence, 
pregnancy can be expected to result in increased renal 
iodine losses. In circumstances of borderline or overt 
iodine defi ciency, increases in GFR could deplete total 
body iodine reserves without the capacity for replen-
ishment if dietary intake remains low (5, 9).Th e main 
reasons for increased iodine requirements during 
pregnancy are: increased thyroid hormone production 
in pregnancy; the increase in maternal GFR because of 
increased losses of ingested iodine; fetal and placental 
consumption of maternal iodine and thyroid hormone 
proportion. Th erefore, the fetal iodine store-support-
ed exclusively by maternal intake, must be continu-
ously refreshed (6).
Th e excretion of iodine in the urine is a good measure 
of iodine intake. Th e median UIC is easily obtainable 
indicator for iodine status, and it is considered a sensi-
tive marker of current iodine intake that refl ects recent 
changes in iodine status (8, 10).
 Th e measurement of urine iodine excretion provides 
the best single measurement of the iodine nutrition-
al status of a population (10), but this indicator does 
not provide direct information about thyroid function 
(11). UICs are, therefore, not useful for the diagnosis 
and treatment of individuals, because an individual’s 
UIC can vary daily, or even within the same day but it 
provides a useful measure of the iodine status of pop-
ulations (12). UIC can be used as a tool to evaluate 
the status of iodine nutrition of population (13) and 
serves as a sensitive parameter of recent iodine intake 
which refl ects the equilibrium between intake and 
excretion (14). Although there are several methods 
for UIC quantifi cation reviewed by Dunn et al. (15). 
World Health Organization (WHO) currently rec-
ommends the Sandell-Kolthoff -method for epidemi-
ological studies (16). Th e status of iodine nutrition of 
a population is determined by measurements of UIC 
since it is considered an indicator of the adequacy of 
the iodine intake of that population (5,8,10).
A joint task force of the WHO, the United Nations 
Children’s Fund (UNICEF), and the International 
Council for the Control of Iodine Defi ciency Disor-
ders (ICCIDD) (17) recommends as parameter for 
the adequacy of the iodine intake in pregnant women, 
UIC range from 150 to 249 μg/L. UIC less than 150 
μg/L have been defi ned as iodine defi ciency (18).
North Macedonia is historically iodine defi cient, but 
due to the long standing and eff ective preventive mea-
sures, it has been considered iodine replete since 2003 
(19). Several studies were conducted in 2002, 2003, 
and 2007 to monitor the iodine status of the Macedo-
nian population and the pregnant women too. Th ese 
studies have confi rmed sustainable suffi  cient iodine 
nutrition in the country (20,21).
Th e aims of this study were divided into primary and 
secondary. Th e primary aims were: First, to assess the 
impact of advancing gestation on UIC in normal preg-
nancy according to the diff erent determined reference 
intervals (trimesters or 5 weeks intervals); second, to 
compare the results of UIC variations over the course 
of pregnancy with other studies and third, to assess 
the maternal status of iodine nutrition determined by 
measurement of UIC and compare it with maternal 
iodine status in other studies. Th e secondary aim of 
our study was to estimate the impact of UIC on some 
neonatal outcomes [gestational age at birth (GAB) and 
birth weight].
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We prospectively investigated UIC in 364 healthy 
pregnant women in diff erent gestational week (g.w.), 
without known thyroid disorder that gave birth at the 
University Clinic of Gynecology and Obstetrics - Sko-
pje. Th ey had a mean age 29.2 ± 5.6 years, and their 
mean body mass index (BMI) was 27.14 ± 4.79 kg/
m2. Th ey signed an informed consent, and the Ethics 
Committee of our institution approved the study.
Inclusion criteria were singleton pregnancy in any ges-
tational age without previous history of thyroid disease 
of the mother or treatment with thyroid drugs. Th e ex-
clusion criteria were as follows: mothers who smoke 
cigarettes, mothers with any chronic disease (diabetes 
mellitus, hypertension), mothers who has personal 
history of thyroid disease or a visible (palpable goiter). 
Th e subjects who took thyroid-related medicine and 
who had some other gynecologic condition (uterine 
fi broids and any fetal anomaly diagnosed with am-
niocentesis or ultrasound) were excluded, too.Th e 
data about maternal age, parity, obstetric history and 
gestational age at the time of birth were noted from 
the medical history. Birth weight for all newborns was 
measured by the midwife attending the birth.
Procedures and criteria 
A sample of 2 mL of urine was taken with special pi-
pette from each participant and added in Eppendorf 
tube. Because of within-day and circadian rhythmicity 
in UI excretion, we collected the urine sample in the 
same time (fasting morning urine samples) specifi ed 
time period between 9 to 10 h P.M. (22). Th e test tubes 
were marked with identifi cation number (ID) and 
frozen at T = -20°C, before being transported. UIC in 
urine samples was analyzed at the National Institute 
for Health and Welfare (THL) in Helsinki (ICP) by 
mass spectrometry (MS) using Agilent 7800 ICP-MS 
system integrated with Agilent SPS 4 auto sampler, 
with the Pinell-modifi ed Sandell Kolthoff  method 
(23), described previously.
Th e threshold criteria for UIC data fi ltering [(UIC < 50 
μg/L, UIC ≥ 100 μg/L) in 5 week (wk) gestation inter-
vals group analysis and (150 μg/L < UIC ≤ 249 μg/L in 
trimester analysis, also (UIC < 150 μg/L) in predictor’s 
analysis] for adequacy of iodine nutrition during cal-
culations were given by WHO, UNICEF and ICCIDD 
recommendations (16, 17, 24).To assess the iodine sta-
tus of a population, the median [not the mean ± SD 
(standard deviation)] UIC is recommended (25). Th e 
median, percentiles and interquartile range (IQR) is 
the preferred measure of central tendency, rather than 
mean and SD, are most commonly used to describe 
the distribution of UIC data (17, 26)
Statistical analysis
Statistical analysis was performed using MedCalc 
Statistical Soft ware version 19.1.3 (MedCalc Soft -
ware bv, Ostend, Belgium; https://www.medcalc.org; 
2019). Normally distributed variables were presented 
as mean and SD. Non-normally distributed variables 
were presented as median and IQR. Some results were 
presented as N (number) or % (percent). Appropri-
ates Kruskal – Wallis H test or Mann-Whitney U test 
were used to found diff erence between UIC values 
among gestation trimester groups or among 5 wk ges-
tational age interval (between more than 3 groups, or 
between two groups), respectively. A t Test for inde-
pendent samples was used to fi nd the diff erence be-
tween symmetrically distributed data. Kernel density 
plot was created to visualize the distribution of UIC 
data over a continuous interval. Bivariate Pearson’s 
correlation test was used to measure the strength and 
direction of relationships between variables. Summary 
plot of notched box-and-whisker diagram with trend 
line were created to show UIC results for each 5 wk 
gestation age period. Multiple backward regression 
analysis was used to show predictable values of in-
dependent variables (maternal BMI, UIC and age as 
predictors) on the dependent variable GAB and birth 
weight. Summarized essential information of UIC in 
meta-analysis according trimester compared with our 
study, according to the WHO recommendation, was 
presented as Forest plot diagram. A disease prevalence 
diagram was created to show prediction value of UIC 
in detection of birth weight.
RESULTS
During the fourth-month period, from April to July 
2017, UIC was assessed in 364 healthy pregnant wom-
en in any gestational week (mean age 29.2 ± 5.6 years). 
Maternal and fetal outcomes characteristics
Sample characteristics of 364 pregnant women and 
some of their fetal outcomes are presented in Table 
1. In the fi rst trimester of pregnancy (up to 12 g.w.) a 
total of 67 (18.41 %) were examined, in the second tri-
mester (12 - 28 g.w.) were examined 100 (27.47 %) and 
in the third trimester (≥ 28 g.w.) were examined 197 
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(54.12 %). Th e mean age of the cohort was 29.2 ± 5.6 
years, with their mean BMI of 27.14 ± 4.79 kg/m2 and 
the mean time of urine sampling was 29.0 ± 10.1 g.w.
Th e median UIC values in each trimester did not de-
viate from the median reference values according to 
the WHO value range (150 – 249 μg/L): in the fi rst 
(207 μg/L, 95% Confi dence Interval [CI] = 197.06 – 
221.60), in the second (189.75 μg/L, 95% CI = 181.97 
– 217.0) and in the third trimester (169.28 μg/L, 95% 
CI = 178.76 – 212.7). Th e overall median UIC during 
pregnancy (183.7 μg/L) and 95% CI (166.71 to 203.66) 
were within the WHO’s reference range, too. 
Appropriate IQR (equal to the diff erence between 75th 
and 25th percentiles) for the trimesters are presented 
in round brackets. We did not found statistically sig-
nifi cant diff erence between median UIC values among 
trimesters (P = 0.418, T statistic = 1.7447; Kruskal 
– Wallis H test) and neither between nor within tri-
mester groups (P = 0.747, P = 0.297 and P = 0.289; 
Mann-Whitney U test). Some of the newborn data 
(GAB and birth weight) are shown at the bottom of 
the table 1, too.
Th e 5th to 95th percentiles range of UIC values for 
overall, fi rst, second and third trimester of pregnancy 
were: 48.024 to 438.023 μg/L, 42.493 to 586.963 μg/L, 
54.453 to 459.778 μg/L and 44.362 to 422.890 μg/L, 
respectively. Th e 25th to 75th percentiles range results 
for UIC are showed in Table 1, too.
Table 1.
Demographic, clinical and other characteristics according to 
gestational trimesters
Kernel density plot
A density plot visualizes the distribution of data [UIC 
(μg/L), x1 – axis] over a continuous interval or time 
period. Density trace graph presents distribution and 
the peak of UIC density, which displays where values 
of UIC are concentrated. Th e y-axis (y1, y2 and y3) in 
a density plot is the probability density function for 
the Kernel density estimation (KDE). Th e fi rst (blue, 
1), the second (red, 2) and the third (green, 3) line are 
presenting a distribution of a diff erent data according 
to the stages of pregnancy. Th e summary diagram of 
three diff erent KDE curves is shown on Figure 1.
Fig 1. Kernel density estimation (KDE) and distribution of 
Urinary Iodine Concentration according to each trimester of 
pregnancy
For data density estimation, we used KDE instead his-
togram, because histogram is not smooth enough to 
present picture of data distribution as it is KDE. On 
y-axis is shown the frequency of individuals present-
ed at the corresponding distance – bin. Th e frequency 
distribution across space aft er dispersal event is shown 
on x-axis: distances from a common origin (binned). 
Th e layouts of the frequencies (den-
sity from 0 to 0.004) of the UIC 
have diff erent variability to the 
value of the mark (UIC). Th e three 
KDE curves are positively skewed, 
or skewed to the right (the mean is 
greater than the median).
Urinary iodine concentration 
according to the gestational age
For a more accurate expression of 
the UIC values variations during 
pregnancy, we divided the gestation period into 8 
subgroups according to a fi ve-week gestational inter-
val. Th e distribution of UIC with two diff erent UIC 
threshold values (UIC < 50 μg/L; UIC ≥ 100 μg/L) and 
Kruskal-Wallis U test between and within groups are 
shown in Table 2. Th e UIC results are presented as me-
dian according to WHO recommendation (25).
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Table 2. Urinary iodine concentration (UIC) and two diff e-
rent UIC thresholds values in diff erent gestational age groups 
with results of Kruskal-Wallis H test
Th e median UIC values in any of the eight gestation-
al age groups did not deviate from the median refer-
ence values according to WHO value range (150 – 249 
μg/L): 152.81, 160.28, 169.41, 175.24, 181.28, 194.39, 
200.13 and 232.34 μg/L, in ascending order, respec-
tively for 3rd, 6th, 7th, 8th, 5th, 4th and 1st gestational age 
group. Th ere is no statistically signifi cant diff erence (P 
= 0.451) in UIC values and maternal age values (P = 
0.102) between and within the eight subgroups (Kru-
skal-Wallis H test and t Test for independent samples, 
for UIC and age, respectively). 
Th e prevalence of pregnant women in this study with 
the median UIC < 50 μg/L is only 5.22% (19 cases), 
and 272 cases (74.72%) from the total were with me-
dian UIC ≥ 100 μg/L. Minimal value of median UIC 
(152.81 μg/L) is registered in third subgroup (15 – 
19.9 wk, median 17 wk).
Distribution of the median urinary iodine 
concentration
Th e UIC results from each 5-week interval from ges-
tation period [median, 95% CI of the median, 25th 
percentiles, 75th percentiles and range] are shown by 
notched box-and-whisker diagram in Fig 2. Th e me-
dian UIC red trend line shows the ascending and de-
scending variation according to the gestational age 
period. Th e WHO range determination for UIC (150 
– 249 μg/L) is showed by green rectangle. Despite the 
visible variations of the median UIC during pregnancy 
showed by red trend line, there is no out of range devi-
ation in UIC, according to the WHO recommendation.
According to the Mann-Whitney test for independent 
samples we found statistical signifi cance (P = 0.046, 
test statistic Z = 1.981) between the UIC values in the 
subgroup A (18 to 21 wk) and the subgroup B (39 to 
41.4 wk). Th e median value for UIC and (95% CI) for 
the median were 200.85 μg/L (153.62 to 289.85) and 
127.27 μg/L (87.17 to 237.99) for subgroup A and B, 
respectively (Fig. 2).
Fig 2. Distribution of the median urinary iodine concentrati-
on through the gestation period
Bivariate Pearson’s correlation analysis
Th e positive value of Pearson product-moment cor-
relation coeffi  cient (r) as measure of the strength of lin-
ear correlation of UIC with maternal and fetal outcome 
characteristics indicated positive, but not signifi cant 
correlation between UIC and birth weight (r = 0.05, 
P = 0.349); UIC and GAB (r = 0.003, P = 0.960); UIC 
and maternal BMI (r = 0.030, P = 0.568) and UIC and 
maternal age (r = 0.019, P = 0.72). An inverse signifi -
cant correlation (P < 0.05) was found between UIC and 
gestational age of pregnancy (r = - 0.107, P = 0.044).
Multiple backward regression analysis
According to the β standardized Coeffi  cient (βst) and 
P-value results from multiple backward regression 
analysis, we found strong positive statistically signif-
icant dependency of dependent variable birth weight 
(βst = 22.5535, P = 0.0004) from maternal BMI as in-
dependent variable. Th is means that any increase of 
maternal BMI results in an increased birth weight. In-
dependent variables (UIC and maternal age) do not 
show statistically signifi cant impact on birth weight: 
(β = 0.1627, P = 0.391) and (β = - 4.7567, P = 0.3782) 
for UIC and maternal age, respectively.
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We found strong inverse statistically signifi cant de-
pendency of dependent variable GAB (β = -0.05560, P 
= 0.0244) from maternal age as independent variable. 
Th is means that any increase of maternal age results in 
a decreased GAB. BMI (β = 0.004688, P = 0.869) and 
UIC (β = 0.0000767, P = 0.929) do not show statis-
tically signifi cant predictable value on the dependent 
variable GAB.
Predictive value of UIC
Selecting option “Plot versus criterion variable (UIC < 
150 μg/L)” in MedCalc, we got a curve of disease prev-
alence i.e. diagram of positive predictive value (%) of 
UIC < 150 μg/L on birth weight (g). We selected a di-
chotomous variable (UIC < 150 μg/L) as classifi cation 
variable: zero (0) for 340 cases with UIC ≥ 150 μg/L 
and one (1) for 24 cases with UIC < 150 μg/L. Birth 
weight (g) was selected as estimated variable. Th e re-
sults for positive predictive value variations (%), dis-
ease prevalence and associate criterion (birth weight) 
are shown in Fig. 3.
Disease prevalence was calculated by the next equa-
tion: Th at means.
Th e maximal sensitivity (45.83%) and specifi city 
(66.27%) of predictor dichotomous variable (UIC < 
150 μg/L) in the predicting of birth weight (associate 
criterion birth weight > 3350 g) is presented as peak 
(black arrow) of the disease prevalence curve, showed 
on Fig 3. Th e receiver operation characteristics (ROC) 
results were: area under curve (AUC) =0.521, z - sta-
tistic = 0.340, P = 0.734, Youden index = 0.121. Ac-
cording ROC, AUC and P – value results, there is no 
statistical signifi cance in predicting birth weight by 
classifi cation variable UIC < 150 μg/L.
Fig 3. Prediction value of UIC in detection of birth weight
Comparison with other studies
Th e diagram called a forest plot (Fig. 4) summarized 
essential information of meta-analysis (the name of 
corresponding author and separate results for medi-
an UIC according for each trimester of pregnancy ac-
cording to the gestation time of urine collection).
Fig 4. A forest plot presentation (blobbogram) of median 
Urinary Iodine Concentration according to the gestation 
trimester of urine collection
Th e vertically placed colored line on numerically di-
vided horizontal line represents the UIC medians for 
each trimester (red for the 1st, green for the 2nd and 
blue line for the 3rd trimester). Th e mutual position of 
each UIC mean among various studies, as well as their 
position according to WHO recommended UIC inter-
val (green rectangle, WHO range) for adequate iodine 
intake in pregnancy, is well understood.
DISCUSSION
We prospectively investigated UIC in 364 healthy 
pregnant women who consequently came to ambu-
lance of gynecological clinic, regardless of the g.w. of 
pregnancy, but we selected them by predetermined 
exclusion criteria. Th e aims of this study were to de-
termine UIC according to the advancing gestation and 
to assess the maternal iodine nutrition status, also to 
correlate the UIC with some neonatal outcomes.
Th e overall median UIC during pregnancy, median 
UIC in the fi rst, second and third trimester did not 
deviate from the median reference value range accord-
ing to the WHO recommendation (criteria for an ac-
ceptable iodine nutritional status in pregnant women) 
(17). Th e 25th to 75th percentiles of UIC values in each 
trimester according to the criteria established by the 
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WHO indicated an acceptable iodine nutrition status, 
in women in our study. With the UIC results of 5th to 
95th percentiles we detected that 5% of the cohort in 
our study have median UIC values smaller than 48.0 
μg/L (and just as much over 438.0 μg/L). According 
the results presented in Table 2, only 5.2% from total 
pregnant women showed UIC < 50 μg/L. Knowing the 
fact that the adequacy of iodine nutrition is defi ned by 
the following criteria: a median UIC ≥ 100 μg/L (with 
allowed presence 20% of the population having UIC < 
50 μg/L) (5, 9), we present adequate population iodine 
nutrition in our cohort. Th is percent is almost 4 times 
smaller than permitted 20% in the general population.
Our results coresponds to the results of Karanfi lski et 
al. from 2005-2007, where the median value for UIC 
for all trimesters in pregnant population was within 
the interval from 150 - 249 μg/L, which corresponds 
to an adequate iodine intake (26). Th ese results, com-
pared to the results from their previous study con-
ducted in 2001 (149.7 μg/L for the fi rst, 157.6 μg/L 
for the second and 130.4 μg/L for the third trimester) 
suggest an increase in the iodine intake among preg-
nant women in a population with a confi rmed iodine 
suffi  ciency (20,26).
However, we must never generalize the given thresh-
olds, range and percent for use in the pregnant popu-
lation. Changes in iodine requirements and maternal 
physiology with advancing gestation may invalidate 
the expected relationship between dietary intake and 
urine iodine excretion (5, 17). A median UIC of 150 to 
249 μg/L has been established to determine the ade-
quate iodine status among pregnant women (17). 
Despite the continual downward trend of the mean 
UIC value from the fi rst to the third trimester, in our 
study (207, 189.75, 169.28 μg/L), we have not con-
fi rmed statistical signifi cant diff erence neither be-
tween nor within the groups (P = 0.418). UIC decreas-
es in the course of pregnancy in our and in most of the 
previously published studies (27 - 32). During the fi rst 
trimester and a few weeks later, the fetus relies on ma-
ternal thyroid hormones, but as the fetal thyroid gland 
begins functioning from 15 to 17 weeks gestation, it 
depends on the maternal iodine supply to maintain 
thyroid hormone production throughout the remain-
der of pregnancy (33). Th e smallest values of the mean 
UIC (152.81) and IQR (133.4) in the third groups (15 
to 19.9 wk, median 17 wk) between series of subgroup’s 
data in our study (Table 2) correlates with requirement 
of a mother iodine increase confi rmed in other studies 
(5, 30, 33) according to the aforementioned fetal thy-
roid start-up function. Th e requirement of a mother 
iodine increase in pregnancy as result of an increased 
requirement for thyroxine (T4), a transfer of T4 and 
iodide from the mother to the fetus and to an increase 
in the iodine loss due an increase in the renal clear-
ance of iodide (34). 
UIC variations during pregnancy sampled by 5 wk in-
tervals are slightly pronounced and gradually down-
ward, so we did not calculate a statistically signifi cant 
diff erence neither between (P = 0.451) nor within 
the groups (P = 0.795). Diff erences in UIC among 
gestational groups in studies with inadequate iodine 
nutrition (depleted iodine status) shown statistical 
signifi cance (P < 0.001)(5, 33, 37). Unlike them, our 
and some other studies (18, 32, 39) with better iodine 
nutritional status, did not showed statistically signif-
icant diff erence between gestational age groups. Th e 
most drastic and only one statistically signifi cant (P = 
0.046) diff erence of UIC among two parts of the gesta-
tional period A (18 to 21 wk) and B (39 to 41.4 wk) in 
our study, once again confi rms the increased maternal 
need for iodine during pregnancy.
Th e trend of median UIC variations throughout preg-
nancy shown in multiple studies is signifi cantly dif-
ferent: during pregnancy UIC decreases continuously 
(32, 35, 36, 38, 40); somewhere it increases continu-
ously (37) but elsewhere alternates its trend: fi rst in-
creases from the fi rst to the second trimester, and then 
decreases from the second to the third trimester (5,18, 
36, 39, 41). For better explanation please see a forest 
presentation shown in Fig. 4. Th e diff erences in medi-
an UIC values and its trend throughout the pregnancy 
in the mentioned studies originate from the following 
characteristics: diff erent time intervals (gestational 
age) in taking the urine samples (trimesters or 5 wk 
interval) or in other words diverse referent intervals; 
diff erence in the way of taking the urine sample: in 
what period of the day is it taken (morning, aft ernoon) 
and if it was always at the same time, is the sample sin-
gle (or twice in a day) or is it a collection of 24h urine; 
diff erences which are coming from if it UIC results 
were corrected in accordance with the renal clearance 
value (GFR); diff erences that are deriving from the 
initial UIC value and coming from iodine nutritious 
status of the pregnant; diff erences in the number of 
participants; diff erences in socio-economy status and 
ethnic variation, level of education, age and other de-
mographic indicators.
Equalizing the gestational sampling time of 24h urine, 
UIC correction according to the GFR, assessment of 
nutritional status with iodine intake and increasing 
the number of participants are necessary tasks that 
should be applied so that UIC can be used to assess 
iodine status in pregnant cohort. Th e large intra-in-
dividual variation in UIC from either spot or 24-hour 
urine samples means that UIC cannot be used to as-
sess iodine status in an individual pregnant woman. 
UIC (μg/L) in spot urine samples could to be about 
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60-65% of the amount excreted in 24 h (42). Th us, 
multiple factors interact in pregnancy to aggravate of 
the real UIC value in each examined individual. How-
ever, in the absence of clearly defi ned reference inter-
vals for iodine excretion (UIC) in pregnancy, studies 
from populations with both adequate iodine nutrition 
and iodine defi ciency provide insight into changes ex-
pected in normal pregnancy (5).
We do not found signifi cant correlation between UIC 
and birth weight (P = 0.349), in accordance with the 
results of other studies (43, 44). Some studies found 
positive association between these variables, but these 
associations were inconsistent across trimesters (45, 
46). Th erefore, variable, inaccurate with the large in-
tra-individual trimester variation in UIC and non-stan-
dardized UIC measurements, make it diffi  cult to cor-
relate with pregnancy outcome. Th at is why declared 
inverse correlation between UIC and examination time 
in our study (P = 0.044) is questionable. In backward 
multiple regression analysis we found that maternal 
BMI as independent variable has a positive impact on 
birth weight (P = 0.0004), only. Th e included indepen-
dent variables (UIC and maternal age) do not showed 
statistically signifi cant impact on birth weight. Includ-
ing UIC, maternal age and BMI in backward multiple 
regression analysis for detecting of predictor impact to 
GAB, we found strong inverse statistically signifi cant 
dependency of dependent variable GAB (P = 0.0244), 
only. Opposite to our study results, Rydbeck et al (2014) 
(47) in cohort of 1617 women [maternal UICs ranged 
from 0.020 to 10 mg/L (median 0.30 mg/L)], presented 
that UIC signifi cantly positively associated with birth 
weight and length for UIC below 1.0 mg/L. Snart et al. 
(2019) (48) collected spot urines samples for UIC in 541 
pregnant women with insuffi  cient iodine concentration 
according WHO. Th ey have not found evidence that 
UIC is adversely associated with the birth outcomes as-
sessed in their study (48). Due to the diff erent results 
in our and in the aforementioned studies about UIC 
association with birth weight, we decided to assess the 
possible predictive value of UIC on birth weight. We 
found that there is no statistical signifi cance in predict-
ing birth weight by UIC. Low values of sensitivity and 
specifi city, low AUC (0.521) of predictor dichotomous 
variable (UIC < 150 μg/L) in predicting birth weight 
results with no statistical signifi cance (P = 0.734).
More extensive analysis of fetal outcome prediction 
and analysis of UIC correlation with other iodine and 
infant parameters was not the main aim of our study, 
but it may be the motive and goal for future studies on 
a similar topic.
Our study has several strengths. First, our cohort in-
cludes 364 pregnant women, a relatively large sample 
size for studies of spot urine. Second, we used the 
Pinell-modifi ed Sandell Kolthoff  ICP-MS method, 
which is a gold standard for quantifying urine iodine. 
Th ird, we collected fasting urine spot samples in the 
same, specifi ed time period (9 to 10h, P.M.) to avoid 
UIC within-day and circadian rhythmicity variation 
in UI excretion. Fourth, the UIC results are shown by 
both, trimester and a 5-week gestational age interval, 
joined in one study.
STUDY LIMITATIONS
Several limitations to this study should be considered. 
Analyzing a single spot urine sample instead of mul-
tiple spot urinary collections or more effi  cient repeat-
ed 24-hour collections is the fi rst and the main lack 
in our study. Th e second limitation is that we did not 
measure urine creatinine levels to provide UI to creat-
inine ratio (UI/Cr), as an indicator for assessment of 
the adequacy UIC, because the serum iodine changes 
are similar to the UI/Cr. Th e UIC results in our study 
are not corrected according to the GFR, which is the 
third limitation. Th e fourth and last limitation is the 
diff erent number of participants in trimester and 
5-week gestational groups which further reduces the 
real estimate of UIC. 
CONCLUSIONS
We have demonstrated that the iodine status of preg-
nant women in our study cohort is generally suffi  -
cient by WHO recommendations. Th e median UIC 
decreased from the fi rst to the third trimester during 
pregnancy, but not with statistical signifi cance. Th e 
overall median UIC values and median UIC in each 
trimester did not deviate from the median reference 
values according to the WHO guidelines, also in any 
of the eight 5-week gestational age groups.Evident de-
crease of median UIC is observed in 5-week gestation-
al age group during pregnancy, which is also statisti-
cally insignifi cant.
Th e most pronounced descending decline in the UIC 
trend curve registered in the section from 5 to 20-
week interval and it’s milder decrease to the end of 
pregnancy is in line with maternal and fetal physiolo-
gy of iodine needs. 
We found strong inversely dependency of GAB from 
maternal age, but not from UIC and BMI, and strong 
positive dependency of birth weight from maternal 
BMI, but not from UIC and maternal age. Because the 
reference interval for UIC to each trimester or 5-week 
interval of pregnancy is not established,it is diffi  cult to 
make an appropriate assessment of correlation of the 
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UIC and birth outcomes. Th e median UIC has no sig-
nifi cance in predicting birth outcome, but is of great 
importance for assessing iodine status in pregnant 
population, more for assessment of population iodine 
nutrition status, than for individual assessment for it. 
Th e validity of a single urine sample for the assessment 
of iodine status in pregnancy and its impact on birth 
outcomes warrants further research. 
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Uvod: Ova je studija utvrdila koncentraciju joda u mokraći (UIC) tijekom trudnoće, procijenila prehrambeni status joda kod 
majke i povezala ga s gestacijskom dobi pri rođenju (GAB) i porođajnom težinom (BW). Mjerenje UIC-a omogućava najbolje 
pojedinačno mjerenje prehrambenog statusa joda u populaciji. Cilj: Određivanje UIC-a trudnicama u sjevernoj Makedoniji.
Metode: Ova prospektivna studija procjenjivala je prehrambeni status joda tijekom trudnoće, pozivajući se na medijan 
UIC 364 zdrave trudnice u različitoj gestacijskoj dobi (u intervalima tromjesečja i 5 tjedana). Rezultati: Ukupna i prosječna 
UIC od 1. do 3. tromjesečja bila su: 183,7, 207, 189,75 i 169,28 [μg / L]. Srednji rezultati UIC (μg / L) prema intervalu od 5 
tjedana u napredovanju trudnoće bili su: 232,34, 200,13, 152,81, 194,39, 181,28, 160,28, 169,41 i 175,24. Otkrili smo 5,22 
% (19/364) i 74,72 % (272/364) s medijanom UIC <50 μg / L, odnosno UIC ≥ 100 μg / L. U višestrukoj regresiji, medijan UIC 
(β = 0,0000767, P = 0,929) nije imao statistički značajno predviđanje za GAB. Rezultati prevalencije bolesti za srednji UIC u 
otkrivanju BW nisu imali statističku značajnost: područje ispod krivulje (AUC) = 0,521, z-statistika (0,340), osjetljivost (45,83 
%), specifi čnost (66,27 %), prediktivna (6,59 %) i P vrijednost (0,734). Zaključak: Jodni status trudnica u našem istraživanju 
u pravilu je dovoljan prema preporukama Svjetske zdravstvene organizacije. Medijan UIC-a u svakom tromjesečju i inter-
valu od 5 tjedana statistički je beznačajno smanjen u skladu s napredovanjem trudnoće. Medijan UIC nema značenje u 
predviđanju GAB i BW.
Ključne riječi: trudnoća, koncentracija joda u mokraći, prehrambeni status joda, težina rođenja, gestacijska dob pri rođenju, 
metabolizam štitnjače
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